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Introduction
The cell’s ability to survive DNA damage relies on the action of 
DNA damage response pathways that delay DNA replica-
tion, halt progression into mitosis, and engage the DNA repair 
machinery. Central to the response to double-stranded DNA 
breaks (DSBs) are two kinases, ataxia telangiectasia mutated 
(ATM) and ATM related (ATR), which are members of the 
phosphatidylinositol-3 kinase–like family. These are recruited 
to DSBs and single-stranded DNA (ssDNA), respectively, to 
phosphorylate key substrates required for cell cycle control and 
activation of DNA repair pathways (for reviews see Shiloh, 2003; 
Bartek and Lukas, 2007). During S phase or G2 phase, recruit-
ment of the MRE11–RAD50–NBS1 (MRN) complex to DSBs 
(Petrini and Stracker, 2003) is thought to trigger ATM phosphory-
lation, which activates two parallel signaling pathways, leading 
to cell cycle arrest and initiation of homologous recombination 
(HR; Jazayeri et al., 2006). The checkpoint effector kinase 
CHK2 is phosphorylated in an ATM- and NBS1-dependent 
manner (Matsuoka et al., 1998, 2000; Buscemi et al., 2001) to 
trigger its activation. In a parallel pathway, the MRN-dependent 
resection of the broken DNA ends generates ssDNA overhangs, 
the substrate for DNA repair reactions by HR. Replication 
protein A (RPA) assembly onto these ssDNA tails triggers ATR-
dependent signaling and activation of the CHK1 checkpoint 
kinase (Zou and Elledge, 2003; Garcia-Muse and Boulton, 2005; 
Adams et al., 2006; Cuadrado et al., 2006; Jazayeri et al., 2006; 
Myers and Cortez, 2006). CHK1 and CHK2 delay cell cycle pro-
gression, in part by inhibiting Cdk activity, which in turn facil-
itates HR initiation by RAD51 filament assembly (West, 2003).
A central role in the process of HR is played by the RAD51 
recombinase (West, 2003). In mammalian cells, a recently char-
acterized family of proteins known as the RAD51 paralogues 
consists of five proteins (RAD51B, RAD51C, RAD51D, XRCC2, 
and XRCC3) related to each other and to RAD51 itself. Their 
precise cellular function remains unknown. Cells lacking the 
RAD51 paralogues are defective in gene targeting and exhibit a 
genomic instability phenotype and high sensitivity to ionizing 
radiation (IR) and DNA cross-linking agents, which are indica-
tive of their role in recombinational DNA repair (Liu et al., 
1998; Takata et al., 2001; French et al., 2002). The paralogues 
form complexes with each other (Masson et al., 2001; Miller 
et al., 2002; Wiese et al., 2002). Specific subcomplexes are 
thought to perform distinct cellular functions. RAD51C and 
XRCC3 but not the other paralogues are part of a complex that 
possesses branch migration and Holliday junction resolution 
T
he RAD51 paralogues act in the homologous re-
combination (HR) pathway of DNA repair. Human 
RAD51C (hRAD51C) participates in branch migra-
tion and Holliday junction resolution and thus is important 
for processing HR intermediates late in the DNA repair 
process. Evidence for early involvement of RAD51 during 
DNA repair also exists, but its function in this context is 
not understood. In this study, we demonstrate that RAD51C 
accumulates at DNA damage sites concomitantly with 
the RAD51 recombinase and is retained after RAD51 
disassembly, which is consistent with both an early and a 
late function for RAD51C. RAD51C recruitment depends 
on ataxia telangiectasia mutated, NBS1, and replication 
protein A, indicating it functions after DNA end resection 
but before RAD51 assembly. Furthermore, we find that 
RAD51C  is  required  for  activation  of  the  checkpoint   
kinase CHK2 and cell cycle arrest in response to DNA 
damage. This suggests that hRAD51C contributes to the 
protection of genome integrity by transducing DNA dam-
age signals in addition to engaging the HR machinery.
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cells showed numerous RAD51C foci, whereas no signal was 
detected in nonirradiated control cells (Fig. 1 B). RAD51C foci 
were detected after irradiation with doses as low as 1 Gy (Fig. S1). 
They were also detected in several other human cell lines (WI38 
and HCT116), but the antibody was not able to efficiently visualize 
RAD51C foci in mouse fibroblasts (unpublished data). Treat-
ment of human cells with two different siRNAs against RAD51C 
efficiently reduced the expression of this protein, as detected by 
immunoblotting (Fig. 1 C). Consistent with this, irradiated cells 
that had been depleted of RAD51C were impaired in their ability 
to form RAD51C foci, which is in contrast to cells treated with 
control siRNA (Fig. 1 D). To further test the specificity of the 
RAD51C monoclonal antibody, we established single-cell clones 
stably expressing hRAD51C from an siRNA-resistant cDNA 
construct (RAD51C*; Fig. S2 A). In irradiated cells transfected 
with vector only, RAD51C depletion by siRNA abrogated forma-
tion of DNA repair foci. However, in cells harboring the siRNA-
resistant RAD51C*, RAD51C foci formation in response to IR 
remained intact. This demonstrates that the anti-RAD51C anti-
body specifically recognized accumulation of the RAD51C pro-
tein into DNA damage–induced foci.
To confirm this localization pattern, we established single-
cell clones stably expressing N-terminally GFP-tagged hRAD51C 
(Rodrigue et al., 2006) at levels comparable with the endoge-
nous protein. In response to partial irradiation of nuclei with 
ultrasoft x rays (2 Gy averaged over the cell), GFP-RAD51C 
accumulated into foci that overlapped with RAD51 (Fig. S2 B). 
Preferential localization of the GFP-RAD51C foci in broad stripes 
within the nuclei, generated by the x-ray mask, further confirms 
its accumulation at sites of DNA damage.
RAD51C foci colocalize with RAD51 but 
persist during DSB repair
RAD51C is required for DSB repair by HR, and a direct protein–
protein interaction of RAD51C with the RAD51 recombinase 
has been reported (Rodrigue et al., 2006). This suggested that 
the two proteins act together in the HR pathway. To investigate 
whether this was the case, irradiated HeLa cells were costained 
with mouse anti-RAD51C and rabbit anti-RAD51 antibodies 
(Fig. 1, E and F). Some of the cells contained mainly RAD51C 
foci (Fig. 1 E, red circle) or RAD51 foci (Fig. 1 E, green circle), 
whereas others contained both types of foci that partly colocal-
ized (65% of RAD51C foci colocalized with RAD51, as deter-
mined by visual inspection; Fig. 1 E, yellow circle). This pattern 
suggests that RAD51C and RAD51 play overlapping but not 
identical roles in response to irradiation.
Detection  of  cells  showing  exclusively  RAD51C  or 
RAD51 staining and of cells in which both proteins colocalized 
suggested that the two activities assemble sequentially at the 
sites of damage. To test this, we monitored the assembly of 
RAD51C and RAD51 foci in response to radiation-induced 
DNA damage in a time course experiment (Fig. 2 A). RAD51 is 
known to form spontaneous foci even in the absence of DNA 
damage, which is a feature not shared by RAD51C (Fig. 1 B). 
These foci are thought to represent stalled replication forks dur-
ing cell cycle progression through S phase (Tarsounas et al., 2003). 
The blue line in Fig. 2 A indicates the frequency of spontaneous 
activities (Liu et al., 2004, 2007). RAD51D, another member of 
the RAD51 paralogue family, associates with telomeres in meiotic 
and somatic cells, and its capping function at telomeres is essen-
tial for telomere integrity (Tarsounas et al., 2004b). In addition, a 
role for RAD51C, XRCC2, and XRCC3 in chromosome segrega-
tion and centrosome integrity has been proposed (Griffin et al., 
2000; Renglin Lindh et al., 2007).
A prominent cytological consequence of DNA damage and 
checkpoint activation is the accumulation of DNA repair and sig-
naling proteins at the sites of damage that can be visualized micro-
scopically as nuclear foci. In response to IR, RAD51 assembles at 
DSB sites with well-defined kinetics and molecular requirements 
(Haaf et al., 1995; Scully et al., 1997). The formation and stability 
of RAD51 foci is dependent on the presence of BRCA2 and the 
five RAD51 paralogues (Yuan et al., 1999; Takata et al., 2001; 
French et al., 2002; Godthelp et al., 2002; Tarsounas et al., 2003, 
2004a). This observation, together with the ability of RAD51 to 
directly interact with both RAD51C and BRCA2 (Chen et al., 
1998b; Wong et al., 1997; Rodrigue et al., 2006), led to the con-
cept that these proteins function as cofactors for RAD51 assembly 
after ssDNA resection at DSB sites. However, although the role of 
BRCA2 as RAD51 loader is supported by both biochemical and 
cell  biological  data,  the  association  of  the  RAD51C–XRCC3 
complex with Holliday junction processing activities suggested 
that the latter proteins may fulfill a role in the late steps of HR, 
downstream of RAD51. How RAD51C acts during the early steps 
of HR and how it promotes RAD51 assembly remain unknown.
In this study, we report that human RAD51C (hRAD51C) 
is recruited to damage sites in response to treatment with IR or 
the replication inhibitor hydroxyurea (HU). The kinetics of 
RAD51C recruitment is consistent with both an early and a late 
role in HR. We further identify an early function of RAD51C in 
DNA repair in facilitating phosphorylation of the checkpoint 
kinase CHK2 and thereby transduction of the damage signal, 
leading to cell cycle arrest and HR activation. Our data iden-
tify RAD51C as a DNA damage response factor required for 
the activation of S and G2/M checkpoints, which could contrib-
ute to the early steps of recombinational DNA repair.
Results
hRAD51C accumulates at DSBs
A major limitation in defining the cellular functions of RAD51 
paralogues was the lack of antibodies sensitive enough to visual-
ize these proteins, which were thought to be expressed at low lev-
els in the cell. In this work, we purified a monoclonal antibody 
raised against full-length RAD51C (Masson et al., 2001) from 
hybridoma cell supernatants, avoiding a low pH elution step (see 
Materials and methods). This antibody reacted with a single major 
band of the expected size for RAD51C in extracts of HeLa and 
U2OS human cells (Fig. 1 A). No obvious change in the abun-
dance or migration of the RAD51C protein was detected in whole 
cell extracts after treatment with IR.
To investigate the role of RAD51C in DSB repair, human 
cell lines (HeLa and U2OS) were subjected to 10 Gy of IR, and 
RAD51C subcellular localization was determined using indirect 
immunofluorescence. After irradiation, a significant portion of 589 CHECKPOINT FUNCTION FOR HUMAN RAD51C • Badie et al.
cells do not assemble RAD51 foci in response to DNA dam-
age (Takata et al., 2000; French et al., 2002). This led to the 
concept that RAD51C acts before RAD51 in the HR pathway. 
Consistent with this, we found that hRAD51C foci precede 
RAD51 foci formation induced after release from HU treat-
ment (Fig. 3 A). In a subset of the cells (20–30%; Fig. 3 B), 
RAD51C foci became detectable within 6 min after removal 
of HU, a time when RAD51 foci were not present. 4 h after 
the  release,  both  RAD51  and  RAD51C  foci  were  present   
in 50–60% of cells, in which they partly colocalized, which 
is  indicative  of  recombinational  activity  during  replication 
fork restart.
Loading of RAD51 at sites of DNA damage in the HR 
pathway requires the tumor suppressor BRCA2 (Davies et al., 
2001). This is thought to be mediated by the ability of BRCA2 
to recruit RAD51 monomers and promote their assembly into a 
RAD51 filament at DSBs. Human CAPAN-1 cells derived from 
a human pancreatic tumor (Goggins et al., 1996; Chen et al., 
1998a) express a truncated form of the BRCA2 protein, which 
compromises their ability to assemble RAD51 foci in response 
to irradiation. In contrast, RAD51C foci formation after irradia-
tion was not affected by loss of BRCA2 function (Fig. 3 C). 
This provides further evidence that RAD51C plays a distinct 
and earlier role than RAD51 at DSBs.
RAD51 foci in nonirradiated control cells. This value was sub-
tracted from the total number of RAD51-positive cells after 
irradiation. At early time points after irradiation, RAD51C and 
RAD51 foci appeared with similar kinetics. Although RAD51 
foci peaked at 1 h after treatment, RAD51C-positive cells fur-
ther increased in number and persisted until 6 h after damage. 
Representative images in Fig. 2 B illustrate these changes. 
To further characterize the relative kinetics of appearance of the 
two types of foci, we computationally determined the number of 
foci in the nuclei of a population of cells (see Materials and 
methods; Fig. 2 C). This analysis revealed that the number of 
RAD51C foci per nucleus increased over time and persisted 
even 6 h after irradiation (Fig. 2 D). In contrast, the number of 
RAD51 foci per cell already reached a peak 40 min after irradia-
tion and decreased over time (Fig. 2 E), with kinetics similar to 
that of manually scored RAD51-positive cells (Fig. 2 A). These 
data are consistent with the possibility that RAD51C acts both at 
the early stages of DSB processing as well as after RAD51-
mediated HR reactions have been completed.
Further evidence for an early role of 
RAD51C during HR
An early role for RAD51C in DNA repair has been suggested 
by observations that RAD51C-defective hamster and chicken 
Figure 1.  hRAD51C forms nuclear foci in response to IR. (A) Western blot detection of hRAD51C. An immunoblot of extracts prepared from irradiated and 
nonirradiated HeLa and U2OS cells was probed with anti-hRAD51C antibody. Recombinant hRAD51C-His10, migrating more slowly because of its epitope 
tag, served as a control. (B) Immunofluorescence detection of RAD51C in paraformaldehyde-fixed HeLa and U2OS cells. Irradiated (10 Gy) and non-
irradiated cultures were stained with anti-hRAD51C monoclonal antibody (red) 2 h after treatment. DNA was counterstained with DAPI (blue). (C) siRNA-
mediated reduction of RAD51C expression. Cells were transfected with control or RAD51C siRNA and irradiated 48 h after transfection. Cell extracts, 
prepared 2 h after irradiation, were analyzed by Western blotting. (D) siRNA-mediated reduction of RAD51C foci. As in C, but cells were fixed 2 h after 
IR and stained with anti-hRAD51C monoclonal antibody (red). Image acquisition parameters were identical for the three samples. (E) Partial colocaliza-
tion of RAD51C and RAD51 in irradiated HeLa cells stained with anti-RAD51C (red) and anti-RAD51 antibodies (green). Nuclei displaying only RAD51C 
or RAD51 foci or containing both types of foci are labeled with a red, green, or yellow circle, respectively. (F) Enlarged image of a cell containing both 
RAD51C (red) and RAD51 foci (green). Bars, 10 µm.JCB • VOLUME 185 • NUMBER 4 • 2009   590
RAD51C foci specifically form during S or G2 phase but not G1 
phase of the cell cycle.
ATM and NBS1 are required for RAD51C 
assembly at DSBs
Repair of DSBs in S and G2 is controlled by the ATM pathway 
(Jazayeri et al., 2006). Therefore, we analyzed whether RAD51C 
recruitment to damage sites depends on ATM. We treated U2OS 
cells with caffeine, which is an inhibitor of the ATM and ATR 
members of the phosphatidylinositol-3 kinase–like family. This 
diminished RAD51C foci formation after irradiation (Fig. S3), 
suggesting that the RAD51C response is regulated by ATM and/
or ATR. To test the dependence of RAD51C recruitment specifi-
cally on ATM, we monitored the cellular response to Ku55933, 
RAD51C foci form in S or G2 phase
During the aforementioned experiments, we noticed that not all 
cells exposed to irradiation developed visible RAD51C foci. 
This could indicate that RAD51C recruitment to DSBs occurs 
during certain stages of the cell cycle but not others. As HR is 
known to act predominantly during S and G2, we used centro-
meric protein F (CENP-F) staining to identify these cells. CENP-F 
has a nuclear diffuse distribution from S phase onwards, be-
comes more intense in G2 phase (Fletcher et al., 2003), and 
shows specific concentration at kinetochores during mitosis. 
The appearance of nuclear RAD51C foci followed a similar pat-
tern in U2OS cells. Radiation-induced foci were detectable in 
cells displaying weak CENP-F staining (Fig. 4 A) and reached 
greater intensity in cells with strong CENP-F. This suggests that 
Figure 2.  Distinct kinetics of RAD51C and RAD51 foci formation. HeLa cells were fixed at the indicated time points after 10 Gy of irradiation and stained 
with anti-RAD51C (red) and anti-RAD51 antibodies (green). DNA was stained with DAPI (blue). (A) More than 100 cells were scored at each time point. 
Nuclei containing >5 foci were counted as positive. The level of spontaneous RAD51 foci in nonirradiated cells (RAD51  IR) is indicated in blue and was 
subtracted from the number of IR-induced RAD51 foci (RAD51 + IR). (B) Representative images of cells at 20, 60, and 360 min after IR. (C) An example 
of a DAPI-stained nucleus (blue) with RAD51C foci (red) processed using TRI2 software. The computer-generated image delineates the nucleus (red) and 
individual foci (blue). (D and E) Computational analysis of RAD51 and RAD51C foci in at least 100 cells at the indicated time points after IR. The blue lines 
indicate the mean number of foci per cell. Bars, 10 µm.591 CHECKPOINT FUNCTION FOR HUMAN RAD51C • Badie et al.
that ATM and NBS1 are required for radiation-induced RPA 
assembly at DSBs (Jazayeri et al., 2006). This indicated that 
RAD51C is regulated by the ATM pathway, similarly to RPA.
RAD51C accumulation at damage sites 
depends on RPA
The ATM and NBS1 dependence of both RAD51C and RPA 
recruitment to damage sites prompted us to test whether both pro-
teins colocalized in response to DNA damage. Indeed, RAD51C 
and RPA foci closely overlapped in all cells after both irradiation 
and release from HU treatment (Fig. 5 A). RPA binds ssDNA 
generated during MRN complex–dependent strand resection. 
To see whether RAD51C affects strand resection, we analyzed 
RPA foci formation in cells depleted of RAD51C. RPA assem-
bled normally in response to irradiation, both in cells treated 
with RAD51C and control siRNAs (Fig. 5 B). As a control, for-
mation of RAD51 foci was efficiently prevented by RAD51C-
depletion under our conditions, as previously reported (French 
et al., 2002; Rodrigue et al., 2006). Conversely, down-regulation 
an ATM-specific inhibitor (Hickson et al., 2004), after irradiation. 
This treatment inhibited formation of RAD51C foci (Fig. 4 B), 
whereas cells treated with solvent (DMSO) were not affected. 
Furthermore, when cells of a fibroblast cell line derived from an 
ataxia telangiectasia patient that is deficient in ATM function 
were irradiated, only 3.2% of the cells formed RAD51C foci. 
The level of RAD51C foci formation was restored to 28.1% of the 
cells by transfection of a complementing vector encoding wild-
type ATM (Fig. 4 C), suggesting that ATM activity is required 
for efficient RAD51C recruitment to sites of DNA damage.
The MRN complex is thought to activate ATM at DNA 
break sites. Therefore, we examined RAD51C recruitment to 
sites of DNA damage in NBS1-deficient Nijmegen breakage syn-
drome fibroblasts. Nijmegen breakage syndrome cells comple-
mented with full-length NBS1 were proficient in RAD51C focus 
formation in response to IR, but cells lacking NBS1 were not 
(Fig. 4, D and E). These results indicate that the recruitment of 
RAD51C requires both functional ATM and NBS1. We also visu-
alized RPA foci as a control in these experiments and confirmed 
Figure 3.  RAD51C assembles before and independently of RAD51 at sites of DNA damage. (A) HeLa cells were incubated with 2 mM HU for 17 h and 
then released into fresh medium. Cells were fixed 0.1 or 4 h after release and stained with anti-RAD51C (red) and anti-RAD51 antibodies (green). (B) For 
each of the two samples in A, at least 100 cells were examined for the presence of RAD51 or RAD51C foci. The mean and standard deviations of three 
independent experiments are shown. (C) CAPAN-1 (Brca2
/tr) cells were irradiated (10 Gy), fixed 2 h after irradiation, and stained with anti-RAD51C (red) 
and anti-RAD51 antibodies (green). Bars, 10 µm.JCB • VOLUME 185 • NUMBER 4 • 2009   592
Figure 4.  RAD51C accumulation at DNA lesions in S/G2 requires ATM and NBS1. (A) U2OS cells were irradiated (10 Gy of IR), fixed after 2 h, and 
stained with anti-RAD51C or anti-RPA (red) and anti–CENP-F antibodies (green). Nuclei were visualized with DAPI (blue). (B) U2OS cells were treated 
with ATM inhibitor (Ku55933) or solvent (DMSO) and then irradiated (10 Gy), fixed 2 h later, and stained with anti-RAD51C (red) and anti-RPA anti-
bodies (green). (C) Atm-deficient cells stably transfected with a vector expressing full-length ATM or an empty vector were treated and processed as in B. 
(D) Nbs1-deficient cells stably transfected with a vector expressing full-length NBS1 or an empty vector were treated and stained as in B. (E) The percentage 
of nuclei exhibiting RAD51C or RPA foci was determined for at least 100 cells from D. The mean and standard deviation of three independent experiments 
are shown. Bars, 10 µm.593 CHECKPOINT FUNCTION FOR HUMAN RAD51C • Badie et al.
Figure 5.  RAD51C assembly at break sites depends on RPA. (A) HeLa cells were irradiated (10 Gy) and fixed 2 h later or treated with 2 mM HU for 17 h, 
released into fresh media, and fixed 4 h after release. Cells were stained with anti-RAD51C (red) and anti-RPA antibodies (green). Nuclei were visual-
ized with DAPI (blue). (B) Control or RAD51C siRNA was cotransfected with a GFP-expressing vector. U2OS cells were irradiated 48 h after transfection, 
fixed after 2 h, and stained with anti-RPA and anti-RAD51 antibodies (red). (C) siRNA-mediated reduction of RPA expression. Cells were transfected with 
control or RPA siRNA and irradiated 48 h after transfection. Cell extracts were analyzed by Western blotting against RPA and tubulin. (D) Control or RPA 
siRNA was cotransfected with a GFP-expressing vector into U2OS cells. Cells were irradiated 48 h after transfection, fixed after 2 h, and stained against 
RAD51C. Bars, 10 µm.JCB • VOLUME 185 • NUMBER 4 • 2009   594
Unlike CHK2, SMC1 phosphorylation remained unaffected 
in the absence of RAD51C. ATM autophosphorylation, which is 
indicative of activation of this kinase in response to DNA dam-
age, was also unaltered by RAD51C depletion (Fig. 7 A).
The impaired CHK2 response in the absence of RAD51C 
became more pronounced in cells exposed to a lower radiation 
dose (1 Gy; Fig. 7 B), whereas CHK1 phosphorylation again re-
mained unaffected. Similar results were obtained with HeLa 
cells exposed to the same dose of IR (Fig. 7 C). Additionally, 
depletion of RAD51C from U2OS cells with a second siRNA 
(RAD51C-1) also led to a reduction in CHK2 phosphorylation 
(Fig. S5 A). Consistent with a RAD51C requirement for effi-
cient checkpoint response, RAD51C-depleted MEFs that en-
tered mitosis with unrepaired DNA breaks also lacked CHK2 
activation (Fig. S5 B).
RAD51C is a component of three distinct RAD51 para-
logue complexes in human cells. A complex formed by RAD51C 
and XRCC3 has been shown to interact with RAD51 (Rodrigue 
et al., 2006). Although biochemical analyses suggested that this 
complex acts in the late stages of HR when Holliday junction 
intermediates are formed, XRCC3 was also reported to assemble 
at sites of DNA breaks before RAD51 (Forget et al., 2004). Thus, 
we tested whether XRCC3 is also required for CHK2 phosphory-
lation in response to DNA damage. Depletion of XRCC3 using 
two different siRNAs diminished CHK2 phosphorylation in re-
sponse to 1 Gy of IR, similarly to RAD51C depletion (Fig. 7 D). 
This suggests that XRCC3 together with, and probably in com-
plex with, RAD51C promotes checkpoint activation at sites of 
DSBs. In a similar experiment, depletion of RAD51 did not 
compromise CHK2 phosphorylation (Fig. S5 C). This is consis-
tent with the possibility that RAD51C and XRCC3 function in 
CHK2 activation independently of RAD51 filament assembly. 
CHK2 phosphorylation was detected in nonirradiated RAD51-
depleted cells, confirming a DNA repair defect in these cells.
RAD51C foci formation in response to IR was unaffected 
in Chk2
/ cells (Fig. 7 E), indicating a role for RAD51C up-
stream of this checkpoint kinase. These results suggest that 
RAD51C is required for ATM-dependent phosphorylation and 
activation of CHK2. In turn, reduced CHK2 activation could 
explain the compromised ability of RAD51C-deficient cells to 
arrest cell cycle progression in response to DNA damage.
Discussion
Evidence for early and late roles for 
RAD51C in HR
RAD51C is essential for the HR pathway of DNA repair. How-
ever, its relationship to RAD51, the central HR activity in mam-
malian cells, has been subject to controversy. Several lines of 
evidence support the notion that RAD51C plays a role in pro-
moting RAD51 nucleoprotein filament assembly early during 
HR: (a) Rad51c-deficient hamster, chicken, and human cell lines 
lack the ability to form IR-induced RAD51 foci (Takata et al., 
2001; French et al., 2002; Bennett and Knight, 2005); (b) over-
expression of RAD51 can partially rescue the DNA repair de-
fect of Rad51c-defective chicken DT40 cells (Takata et al., 
2001); (c) the human RAD51B–RAD51C complex functions as 
of RPA expression completely abolished RAD51C foci forma-
tion (Fig. 5, C and D). These data establish that RAD51C co-
localizes with RPA and requires RPA binding to ssDNA for its 
recruitment. Therefore, RAD51C is likely recruited to sites 
of DSBs after ATM- and NBS1-dependent strand resection and 
RPA association but before RAD51 filament assembly. How 
RPA promotes RAD51C recruitment is currently not known. 
Coimmunoprecipitation experiments did not provide evidence 
for a direct interaction between the two proteins (Fig. S4).
RAD51C is required for the checkpoint 
response to DNA damage
In addition to its role in DNA repair, RPA is required for check-
point activation to halt cell cycle progression in response to 
damage (Zou and Elledge, 2003; Jazayeri et al., 2006). There-
fore, we analyzed whether RAD51C might also be required for 
the DNA damage checkpoint response. We transfected U2OS 
cells with either control siRNA or RAD51C-specific siRNA, ir-
radiated the cells 48 h after transfection, and analyzed their cell 
cycle distribution by FACS analysis 2 h thereafter. RAD51C-
proficient cells accumulated in S phase after irradiation with 1 Gy, 
whereas RAD51C-depleted cells failed to do so and instead 
showed an increase in G2/M-phase DNA content (Fig. 6 A). No 
statistically significant differences were found between GFP- 
and RAD51C siRNA–treated cells in the absence of IR. This 
suggests that RAD51C is required to delay cell cycle progres-
sion through S phase in response to DNA damage. Furthermore, 
control cells showed a reduction in the frequency of mitotic 
cells positive for phosphorylated histone H3 after irradiation 
(Fig. 6 B), which is indicative of arrest at the G2/M transition in 
the presence of unrepaired DNA lesions. Also this arrest was 
significantly less pronounced in RAD51C-depleted cells, sug-
gesting compromised control of G2/M progression. In addition, 
we found that primary mouse embryonic fibroblasts (MEFs), in 
which RAD51C expression was inhibited using retrovirally de-
livered short hairpin RNA (shRNA), entered mitosis in spite of 
the presence of unrepaired chromatid and chromosome DNA 
breaks (Fig. 6, C and D). A marked increase in chromatid and 
chromosome breaks in response to RAD51C depletion was ob-
served in MEFs obtained from two littermate embryos (Fig. 6 E), 
which is indicative of a DNA repair defect and lack of check-
point control of progression into mitosis.
RAD51C inhibition results in reduced 
CHK2 phosphorylation
To gain insight into the mechanism by which RAD51C mediates 
checkpoint integrity, cells depleted of RAD51C were assessed 
for their ability to phosphorylate and thereby activate the down-
stream checkpoint kinases CHK1 and CHK2 in response to 
damage. In U2OS cells exposed to a radiation dose of 10 Gy, 
RAD51C depletion did not affect phosphorylation of CHK1 on 
Ser 317 (Fig. 7 A). Instead, it caused reproducible reduction in 
CHK2 phosphorylation on Thr 68. CHK2 is phosphorylated and 
activated by ATM in response to damage (Matsuoka et al., 2000). 
To analyze whether phosphorylation of other ATM targets   
in addition to CHK2 was impaired in the absence of RAD51C, 
we analyzed phosphorylation of the ATM substrate SMC1. 595 CHECKPOINT FUNCTION FOR HUMAN RAD51C • Badie et al.
Figure 6.  RAD51C promotes cell cycle arrest in response to DNA damage. (A) RAD51C depletion reduces IR-induced S-phase delay. U2OS cells were irradiated 
(1 Gy) 48 h after transfection with control or RAD51C siRNA and, 2 h later, fixed for propidium iodide staining and flow cytometry. G1, S, and G2/M popu-
lations were assigned using CellQuest. (B) Analysis of the G2/M checkpoint. As in A, but cells were stained with an antibody against phosphorylated histone 
H3 and propidium iodide. (A and B) The mean and standard deviation from three independent experiments are shown. Significance in difference between the 
grouped values was tested using an unpaired t test. (C) shRNA-mediated reduction of RAD51C expression in primary MEFs. Cells were infected twice at 12-h 
intervals with retroviruses expressing control or RAD51C shRNA and then selected with puromycin for 48 h. Cell extracts prepared 3 d after the first infection 
were analyzed by Western blotting against mouse RAD51C and tubulin. (D) Cells treated as in C were incubated with colcemid for 4 h and processed for 
FISH analysis of metaphase chromosome spreads with a Cy3-conjugated telomeric peptide nucleic acid probe (red). Arrowheads point to chromatid breaks.   
(E) Quantification of chromatid and chromosome break frequencies in metaphase spreads from MEFs established from two littermate embryos, each transfected 
with either control or RAD51C shRNA. 30–50 metaphases were analyzed for each sample. Bar, 10 µm.JCB • VOLUME 185 • NUMBER 4 • 2009   596
interacts directly with RAD51 in human cells after etoposide 
treatment (Rodrigue et al., 2006). A substantial set of data also 
supports the idea that RAD51C acts at late HR stages, after the 
RAD51-mediated strand invasion reaction has been completed. 
mediator of RAD51 nucleoprotein complex assembly (Sigurdsson 
et al., 2001); (d) hXRCC3, an interacting partner of RAD51C, 
assembles at DSBs early during DNA repair (Forget et al., 2004). 
Consistent with this, it was reported recently that RAD51C 
Figure 7.  RAD51C is required for IR-induced CHK2 phosphorylation. (A) U2OS cells were transfected with control or RAD51C siRNA and irradiated 
(10 Gy) 48 h after transfection. After 2 h, extracts were prepared and immunoblotted as indicated. (B) As in A, but cells were treated with 1 Gy of IR, and 
protein samples were analyzed after 0.5, 1, and 2 h. (C) As in B, but using HeLa cells. (D) U2OS cells were transfected with a control siRNA or two differ-
ent siRNAs against XRCC3 and irradiated (1 Gy) 48 h after transfection. After 2 h, extracts were prepared and immunoblotted as indicated. (E) HCT116 
Chk2
/ cells were treated with 10 Gy of irradiation and fixed 2 h after. Cells were stained with anti-RAD51C (red) and anti-RPA antibodies (green). 
(F) Model for RAD51C action in response to DSBs in S/G2. RAD51C is recruited by RPA to break sites, where it facilitates CHK2-mediated cell cycle arrest 
and assembly of the HR machinery. Bar, 10 µm.597 CHECKPOINT FUNCTION FOR HUMAN RAD51C • Badie et al.
et al., 2002; Rodrigue et al., 2006). In this study, we demonstrate 
that, in addition to promoting RAD51 assembly, RAD51C is re-
quired for efficient checkpoint signaling to delay cell cycle pro-
gression in response to DNA damage. This function is shared 
between RAD51C and RPA, and we find that both proteins as-
semble in coinciding foci at sites of damage, specifically during 
S/G2 phase of the cell cycle. RPA foci form in the absence of 
RAD51C, suggesting that strand resection activities and RPA 
association with ssDNA do not require RAD51C. Conversely, 
RAD51C relies on RPA for its assembly at the break. This indi-
cates that RAD51C requires RPA to mediate its association with 
the break site.
RPA-coated ssDNA is generated in an ATM-dependent 
manner (Jazayeri et al., 2006) and facilitates recruitment of the 
ATR–ATR-interacting protein complex (Zou and Elledge, 2003), 
leading to phosphorylation of the CHK1 checkpoint effector 
kinase. In this study, we report that RAD51C plays a similar 
role in checkpoint signaling by promoting phosphorylation and 
thereby activation of the CHK2 kinase. This role is shared by 
XRCC3, which is also a member of the RAD51 paralogue fam-
ily and interacting partner of RAD51C. Both ATM and NBS1 
are required for CHK2 phosphorylation in vivo (Matsuoka   
et al., 1998; Buscemi et al., 2001; Falck et al., 2001), and ATM 
has the ability to directly phosphorylate CHK2 in vitro (Matsuoka 
et al., 2000). RAD51C is also regulated by both factors, and 
potential ATM  phosphorylation  sites  have  been  identified 
(Matsuoka et al., 2007). Whether RAD51C is a target for ATM 
phosphorylation remains to be investigated.
It is interesting to note that RAD51C is recruited to DNA 
break sites only in the S/G2 phase of the cell cycle. This is con-
sistent with CHK2 activation in response to DNA damage during 
G1 occurring independently of RAD51C. Indeed, in vitro recon-
stitution experiments suggest that the MRN complex is sufficient 
to promote ATM activation and CHK2 phosphorylation at paired 
duplex DNA ends. Such ends likely model DNA breaks in G1, 
which is consistent with the observation that CHK2 is phosphory-
lated in response to DNA damage in G1 (Matsuoka et al., 1998; 
Lee and Paull, 2005). In experiments using a cell-free extract 
system, Shiotani and Zou (2009) have demonstrated that 3 
ssDNA overhangs, as generated during DNA break processing in 
S/G2, are inhibitory to ATM activation and CHK2 phosphoryla-
tion when compared with unprocessed ends. Therefore, it is con-
ceivable that, in vivo during the S/G2 phases of the cell cycle, 
additional factors act at DNA ends to promote the generation 
and/or propagation of the checkpoint signal. Our results identify 
RAD51C as one such factor with a role in transduction of the 
checkpoint signal to CHK2. How RAD51C acts at DNA break 
sites to achieve this is an interesting question for future studies. 
It is possible that such a role could be direct, with RAD51C act-
ing to recruit or mediate recruitment of canonical checkpoint 
proteins. Alternatively, it is possible that RAD51C plays an indi-
rect role, being required for structural chromatin changes at the 
break site that allow efficient generation or propagation of the 
checkpoint signal. Both could be consistent with a more pro-
nounced requirement for RAD51C at low IR doses.
An important implication of our results is that RAD51C 
controls RAD51 filament and HR activation at multiple levels, 
This includes (a) association of Holliday junction branch migra-
tion and resolution activity with RAD51C in human cell ex-
tracts (Liu et al., 2004), (b) reduced Holliday junction resolution 
activity in Rad51c-defective hamster cells and MEFs (Liu et al., 
2004; Kuznetsov et al., 2007), (c) RAD51C–XRCC3 complex 
binding to Holliday junctions in vitro (Liu et al., 2007), (d) main-
tenance of RAD51C foci on mouse meiotic chromosomes at 
late prophase I stages, at the time of Holliday junction resolution 
(Liu et al., 2007), and (e) broken chromatids in mouse oocytes 
expressing a hypomorphic Rad51c allele in metaphase II, which 
is linked to a defect in meiotic Holliday junction resolution 
(Kuznetsov et al., 2007).
In this study, we have used a monoclonal antibody to char-
acterize the behavior of hRAD51C at sites of radiation-induced 
DNA damage. RAD51C accumulates in nuclear foci, which 
identify sites of damage, as judged by the colocalization with 
other DNA repair proteins, RAD51 and RPA. Colocalization of 
RAD51C with RAD51 foci is only partial, which is consistent 
with overlapping but not coinciding functions for these proteins. 
The kinetics and dependencies of recruitment of the two pro-
teins at break sites delineate an ordered assembly pathway 
(Fig. 7 F). RAD51C recruitment to break sites requires ATM 
and NBS1 activities involved in strand resection at DSBs as well 
as RPA, which decorates the ssDNA overhangs produced. In 
response to IR, RAD51C appears at break sites with roughly 
similar kinetics as RAD51 (Fig. 2 A). After release from HU-
induced replication arrest, RAD51C foci appeared distinctly 
before RAD51, indicating that under these conditions RAD51C 
acts before recruitment of the recombinase. In Brca2-deficient 
cells, RAD51C foci form in response to radiation, whereas 
RAD51 fails to associate with damage sites. Therefore, we pro-
pose that, during the early stages of DNA break repair by HR, 
RAD51C, possibly alone or more likely in complex with other 
paralogues, acts as a platform for the assembly of RAD51 
filaments from RAD51 monomers delivered to the DSB by 
BRCA2. Thereafter, although RAD51 dissociates again from 
the break sites as recombination reactions proceed, RAD51C 
persists for distinctly longer periods of time. Thus, RAD51C 
could act as a recruitment platform for postinvasion HR activ-
ities (i.e., Holliday junction branch migration and resolution) 
in the late stages of DSB repair. Of the five members of the 
RAD51 paralogue family, only RAD51C has been shown to be 
part of several subcomplexes: RAD51B–RAD51C–RAD51D–
XRCC2, RAD51B–RAD51C, and RAD51C–XRCC3 (Masson 
et al., 2001; Sigurdsson et al., 2001; Wiese et al., 2002). It is not 
clear from our current experiments whether RAD51C associ-
ates with DSBs continuously throughout repair or whether there 
is an early and a late wave of distinct RAD51C-containing protein 
complex assembly at break sites. Answers to this question await 
the availability of higher sensitivity antibodies against other 
members of the RAD51 paralogue family.
A role for RAD51C in DNA  
damage signaling
Previous studies suggested the possibility that the early role of 
RAD51C in DNA repair is that of facilitating assembly of RAD51 
filaments at sites of DNA damage (Takata et al., 2001; French JCB • VOLUME 185 • NUMBER 4 • 2009   598
Immunofluorescence
For indirect immunofluorescence staining, cells were seeded onto coverslips 
24 h before irradiation. When CAPAN-1 cells were used, coverslips were 
coated with a solution of 0.1 mg/ml fibronectin before plating the cells. 
After irradiation, cells were allowed to recover for the indicated times, 
washed in PBS, and swollen in hypotonic solution (85.5 mM NaCl and 5 mM 
MgCl2, adjusted to pH 7.0) for 5 min. For ultrasoft x ray–treated cells, 0.1% 
Triton X-100 was added to the hypotonic solution. Cells were fixed with 4% 
paraformaldehyde for 10 min at room temperature, permeabilized by add-
ing 0.03% SDS to the fixative, and immunostained as described previously 
(Tarsounas et al., 2003). For time point collection, cells were kept in PBS on 
ice for up to 2 h before processing. Dried coverslips were mounted on micro-
scope slides using the ProLong Antifade kit (Invitrogen) supplemented with 
1 µg/ml DAPI. Specimens were viewed with an inverted microscope 
(DMI6000B; Leica) and fluorescence imaging workstation equipped with 
an HCX Plan-Apochromat 100× NA 1.4-0.7 oil objective, and images 
were acquired at room temperature using a digital camera (DFC350 FX R2; 
Leica) using LAS-AF software (Leica). Brightness and contrast adjustments 
were applied to the whole image using Photoshop CS3 (Adobe).
Immunoblotting
Cells were harvested by trypsinization, washed once with cold HBSS, and 
resuspended in cold buffer A (10 mM Hepes, pH 7.9, 10 mM KCl, 1.5 mM 
MgCl2, 0.3 M sucrose, 10% glycerol, 1 mM DTT, and 0.05% Triton X-100) 
supplemented  with  protease  and  phosphatase  inhibitor  cocktail  tablets 
(Roche) at a concentration of 2 × 10
7 cells/ml. After extraction on ice for   
5 min, the cell suspension was cleared by centrifugation at maximum speed 
in a bench-top centrifuge (model 5424; Eppendorf). The nuclear pellet was 
resuspended in SDS-PAGE loading buffer and sonicated. Equal amounts of 
protein  (50–100  µg)  were  analyzed  by  gel  electrophoresis  followed  by   
Western blotting. NuPAGE-Novex 10% Bis-Tris and 10% Tris-Gly gels (Invitro-
gen) were run according to the manufacturer’s instructions. Antitubulin, anti–
histone H3, or anti–histone H2AX antibody was used for a loading control.
Antibodies
Mouse  monoclonal  antibodies  2H11  raised  against  hRAD51C,  10F1 
raised against human XRCC3, 3E1 raised against GFP, and TAT-1 raised 
against -tubulin (Masson et al., 2001; Tarsounas et al., 2004b) were ob-
tained from the Cancer Research UK monoclonal antibody service. Mouse 
IgGs were purified from hybridoma supernatants using Gentle Ag/Ab Elu-
tion Buffer (Thermo Fisher Scientific). Rabbit polyclonal antibodies were 
raised against full-length RAD51 (FBE2; Barlow et al., 1997) and the 70-kD 
subunit of RPA (SWE34; a gift from S. West, Cancer Research UK, Hert-
fordshire,  England,  UK).  Additional  antibodies  used  were  anti-H2AX 
(EMD); anti–histone H3 (a gift from A. Verreault, University of Montréal, 
Montréal, Quebec, Canada); anti–CENP-F (Abcam); anti–phospho histone 
H3–Ser 10 (6G3), anti–phospho CHK1–Ser 317, anti–phospho CHK2–Thr 
68, and anti-CHK2 (all from Cell Signaling Technology); anti–phospho 
CHK2 (R&D Systems); anti-CHK2/Cds1 (Millipore); and anti-SMC1 and 
anti–phospho SMC1–Ser 966 (Bethyl Laboratories, Inc.). The anti–mouse 
RAD51C rabbit serum MTA37 was generated against the N-terminal pep-
tide RELVGYPLSPAVRGKGKLVAAGFQTAED. The serum was affinity purified 
using the peptide cross-linked to Sulfo Link gel (Thermo Fisher Scientific).
RNAi
HeLa and U2OS cells were transfected using Oligofectamine (Invitrogen). 
In brief, 0.2–0.5 × 10
6 cells/well of a 6-well plate were plated 24 h before 
transfection. Cells were transfected with 2 µg siRNA/well twice at 7-h time 
intervals and processed 48 h later. siRNA duplexes were 21 base pairs 
with a 2-base deoxynucleotide overhang (Thermo Fisher Scientific). The se-
quences of RAD51C siRNAs were 5-CACCTTCTGTTCAGCACTAGA-3 
(51C siRNA; Rodrigue et al., 2006) and 5-GAGAATGTCTCACAAATAA-
3 (51C-1 siRNA); the sequences of XRCC3 siRNAs were 5-GAATTATT-
GCTGCAATTAA-3  (X3  siRNA)  and  5-GCCAGATCTTCATCGAGCA-3 
(X3-1 siRNA; Rodrigue et al., 2006); the sequence of RPA siRNA was 
5-AACACTCTATCCTCTTTCATGTT-3 (Zou and Elledge, 2003; McCabe 
et al., 2006); and the sequence of RAD51 siRNA was 5-CTTTGGCCCA-
CAACCCAT-3. A GFP siRNA with the sequence 5-GCTGACCCTGAA-
GTTCATCTT-3 (Tarsounas et al., 2004b) was used as a control. For 
expression of siRNA-resistant RAD51C (RAD51C*), the plasmid pcDNA3-
RAD51C  was  modified  by  site-directed  mutagenesis  as  previously  de-
scribed (Rodrigue et al., 2006).
Computational RAD51 and RAD51C foci analysis
Image analysis was performed after acquisition using the TRI2 software 
package, based on the Compact Hough and Radial Map algorithms 
the earliest of which is by modulating the DNA damage signal 
emanating from DSBs, which halts cell cycle progression and 
reduces Cdk activity. In turn, this allows BRCA2 to interact with 
RAD51 and engage the RPA-coated ssDNA in HR reactions 
leading to repair (Jazayeri et al., 2006). In support of this model, 
we observed similar cell cycle regulation of IR-induced RAD51C, 
RPA, and RAD51 focus formation, all being restricted to S and 
G2 (Yuan et al., 2003; unpublished data).
The cell cycle arrest defect observed in RAD51C-depleted 
cells in response to IR could be explained by reduced CHK2 
phosphorylation. CHK2 is phosphorylated in both S and G2 
cells exposed to IR and controls the intra-S checkpoint (Falck 
et al., 2001) as well as Cdk activity required for the G2/M transi-
tion (Matsuoka et al., 1998). Consistent with RAD51C-dependent 
regulation of CHK2 activation, we observe both a less robust 
S-phase delay and an increase in the fraction of cells entering 
mitosis 2 h after DNA damage. RAD51C-defective cells accumu-
late endogenous DNA damage and enter mitosis with unrepaired 
DSBs, most likely as the result of defective CHK2-dependent 
checkpoint control at the G2/M transition. Conversely, RAD51C 
accumulation  at  sites  of  damage  seems  unaffected  by  the   
absence of CHK2. Furthermore, RAD51C function in check-
point mediation appears independent of RAD51 filament assem-
bly, as lack of RAD51 does not affect integrity of the CHK2 
checkpoint. Together, our data support a role for RAD51C as   
a mediator in the early steps of DNA damage signaling (Fig. 7 F) 
in  addition  to  its  role  in  promoting  HR  reactions  at  the   
break sites.
Materials and methods
Cell culture and treatments
HeLa 1.2.11 (Tarsounas et al., 2004b), U2OS, HCT116 wild-type, and 
Chk2
/ cells (a gift from F. Bunz, John Hopkins University, Baltimore, MD; 
Jallepalli et al., 2003), and NBS1 LB1 cells infected with pLPC-NBS1 or 
pLPC (a gift from M. Zdziencka, University of Leiden, Leiden, Netherlands; 
Kraakman-van der Zwet et al., 1999) were cultivated in monolayers in Dul-
becco’s minimum essential medium (Invitrogen) supplemented with anti-
biotics (penicillin and streptomycin; Sigma-Aldrich) and 10% FBS (Invitrogen). 
Ataxia  telangiectasia  fibroblasts  transduced  with  empty  vector  or  ATM 
(GM16666 and GM16667, respectively; Coriell Institute Repository) were 
grown under similar conditions except that medium was supplemented with 
15% FBS. Human CAPAN-1 cells were cultivated in 2% RPMI medium sup-
plemented with 15% FBS.
Single-cell clones were established as previously described (Bekker-
Jensen  et  al.,  2006).  In  brief,  U2OS  cell  lines  stably  expressing  GFP-
RAD51C  (a  gift  from  J.-Y.  Masson,  Laval  University  Cancer  Research 
Center, Quebec City, Quebec, Canada) or RAD51C* were generated by 
transfecting the expression construct alone (RAD51C*) or together with the 
pBabe–puro construct. After selection with 3 µg/ml puromycin for 14 d, 
single-cell clones were derived by serial dilutions in 96-well plates and 
tested for expression of the target protein.
 irradiation was performed using a 
137Cs source at the dose indi-
cated. The ATM inhibitor Ku55933 (a gift from G. Smith, AstraZeneca, 
Manchester, England, UK; Hickson et al., 2004) was added at 10-µM final 
concentration for 30 min before irradiation. Caffeine (Sigma-Aldrich) was 
added at 5-mM final concentration 2 h before irradiation. For HU treat-
ment, cells were incubated 8–12 h after seeding with 2 mM HU for 17 h. 
Then, cells were incubated with fresh medium for the indicated period of 
time. For the 1.5 keV ultrasoft x-ray irradiation, cells were plated on the 
0.9-µm thick Mylar base of an irradiation dish. The dish was placed in 
contact with an irradiation mask patterned with a 1-µm thick gold grid, 
through which the cells were irradiated. The grid consists of a series of 
9-µm wide stripes separated by 1-µm gaps, resulting in cells being irradiated 
with a series of 1-µm stripes at 10-µm intervals.599 CHECKPOINT FUNCTION FOR HUMAN RAD51C • Badie et al.
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(Barber et al., 2001, 2007). The algorithm was used to detect nuclei and 
then to count foci within the nuclei from images acquired using DAPI and 
Cy3 fluorescent channels.
G2/M checkpoint assay
The G2/M checkpoint assay was performed as previously described (Kolas 
et al., 2007). In brief, U2OS cells were transfected with control or RAD51C 
siRNA twice at 18-h time intervals, as described in RNAi, and, 48 h later, 
were exposed to 1 Gy of IR. After 2 h, cells were harvested, washed twice 
in PBS, and fixed in 1% paraformaldehyde at 37°C for 10 min. After per-
meabilization in ice-cold 90% methanol, cells were washed in PBS and 
stained with anti–phospho histone H3–Ser 10 antibody followed by Alexa 
Fluor 488–conjugated goat anti–mouse IgG secondary antibody (Invitro-
gen). Cells were incubated with 5 µg/ml propidium iodide and 0.25 mg/ml 
RNase I in PBS. At least 10,000 cells were analyzed by flow cytometry (BD 
Biosciences). Data were processed using CellQuest (BD Biosciences).
MEF retroviral transduction and metaphase preparation
Primary MEFs were isolated from day 13.5 embryos as previously de-
scribed (Blasco et al., 1997) and cultivated in Dulbecco’s minimum essen-
tial  medium  supplemented  with  antibiotics  (penicillin  and  streptomycin) 
and 10% FBS. Retroviral transduction of primary MEFs was performed as 
previously described (Palmero and Serrano, 2001). In brief, HEK293T 
packaging cells were grown to 70% confluency and transfected with   
pRetroSuper-shRNA and pCL-Eco helper vector using a standard calcium 
phosphate protocol. The media was replaced 24 h after transfection. Recipient 
MEFs were plated and infected 24 h later with the retroviral supernatants 
produced by the HEK293T cells. Additional infections were performed 
after 24 and 36 h. 24 h after the last infection, cells were washed and 
incubated with fresh media containing 2 µg/ml puromycin for 48 h.   
Exponentially  growing  MEFs  (obtained  from  A.  Zelensky,  Medical  Re-
search  Council,  Harwell,  England,  UK)  were  either  collected  and  pro-
cessed  for  Western  blot  analysis,  as  described  in  Immunoblotting,  or 
incubated with 0.1 µg/ml colcemid (Invitrogen) for 4 h at 37°C and then 
fixed in methanol/acetic acid (3:1). FISH was performed as previously de-
scribed  (Tarsounas  et  al.,  2004b)  using  15  µg/ml  Cy3-conjugated 
PNA[CCCTAA]3 telomeric probe (Applied Biosystems), and chromosomes 
were visualized with DAPI.
Online supplemental material
Fig. S1 illustrates formation of RAD51C foci in response to increasing 
doses of irradiation. Fig. S2 demonstrates the specificity of the RAD51C 
monoclonal antibody and accumulation of GFP-RAD51C foci in nuclear 
stripes induced by partial irradiation of cells with ultrasoft x rays. Fig. S3 
shows inhibition of IR-induced RAD51C foci by caffeine. Fig. S4 examines 
a possible physical interaction between RAD51C and RPA. Fig. S5 shows 
lack of CHK2 activation in irradiated U2OS cells depleted of RAD51C 
using  a  second  siRNA  (RAD51C-1)  as  well  as  in  RAD51C-depleted 
MEFs  and  normal  CHK2  activation  in  irradiated  U2OS  cells  depleted 
of RAD51. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.200811079/DC1.
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